Category: Manufacturing

April 28, 2023

Yposkesi, SK pharmteco’s clinical and commercial viral vector manufacturing arm for cell and gene therapies, launched LentiSure, an optimized Lentiviral (LV) Vector manufacturing platform for increasing lentivirus production efficiency and robustness. Lentivirus or LV vectors are used to produce cell-based […]

April 26, 2023

Cell therapies are powerful weapons for treating some cancers, but the manufacturing required is complex and time-consuming. Bristol Myers has previously had difficulties producing enough of its two CAR-T cancer therapies to keep up with demand. Bristol Myers won approval […]

April 17, 2023

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company addressing serious diseases with significant unmet need, has entered into a manufacturing collaboration agreement with Cook MyoSite, Inc. to facilitate chemistry, manufacturing, and control (CMC) documentation for Lipella’s drug candidate LP-10 (liposomal tacrolimus), […]

April 12, 2023

Meissner, a company focused on advanced microfiltration and therapeutic manufacturing systems, announced on April 6, 2023 that it will invest nearly $250 million in a new manufacturing facility in Athens-Clarke County, Ga. The new facility will be located at the […]

March 23, 2023

Are you ramping up for clinical development, and deciding which CDMO to outsource your biologic? Learn more about how to efficiently qualify a new biomanufacturing partner organization for their fit with your timelines, budgets, and regulatory needs. This webinar will […]

March 17, 2023

Sandoz, the generics and biosimilars division of Novartis, announced on March 9, 2023 that it has signed a memorandum of understanding to build a new biologics production plant in Lendava, Slovenia. The company expects to invest at least $400 million […]

February 6, 2023

BioNTech announced on Feb. 2, 2023 that it has completed construction of its first proprietary plasmid DNA manufacturing facility in Marburg, Germany. The investment of approximately €40 million is part of a long-term development plan aiming to increase the company’s […]

February 1, 2023

Biologics, especially protein drugs, are often produced in cultured cells. Those cultured cells, called host cells, synthesize the target proteins along with the proteins coded by the cell genome for the cells’ own survival, function, and reproduction. Purifying the target […]

January 24, 2023

Eli Lilly will invest $450 million in a North Carolina manufacturing plant to meet growing demand for its diabetes drugs Mounjaro and Trulicity, the company said Tuesday. The investment in the Research Triangle Park plant will expand filling, device assembly […]

January 24, 2023

A just-published report from the Medicines Manufacturing Industry Partnership (MMIP) – set up by the UK government and biopharma industry in 2014 to drive growth in the category – says the sector has the potential to be a driver for […]

January 9, 2023

Ginkgo Bioworks, which is building a platform for cell programming and biosecurity, has opened Bioworks7, the latest expansion of its biological engineering foundry. With this new space, Ginkgo increases its capacity and capabilities to serve its partners in the spaces […]

December 13, 2022

Green Bioactives, a startup that sustainably biomanufactures plant-derived bioactives, has raised £2.6 million ($3.1 million) in seed financing. Their platform can identify, isolate, and cultivate plant vascular stem cells—which can differentiate into distinct plant tissues—for different purposes, allowing the production […]

December 9, 2022

Catalent – a company aiming to boost the supply of better patient treatments – has announced the opening of a new commercial-scale cell therapy manufacturing facility at its European centre of excellence for cell therapies in Belgium. The new facility […]

October 31, 2022

Lannett Company, Inc. has received approval from the US Food and Drug Administration (FDA) to manufacture Numbrino, the company’s branded topical anesthetic product, at its main plant in Seymour, IN. The company previously manufactured Numbrino and other liquid drug products […]

September 16, 2022

The White House hopes to expand US modern biotech manufacturing and reduce reliance on foreign sources of bioindustrial materials. An important component of the White House initiative to speed the development of innovative cancer therapies and other critical treatments for […]

September 12, 2022

Novartis will spend $300 million to bolster its development and production capabilities for biologic medicines, which make up an increasing share of its drug pipeline. The Swiss drugmaker will invest $110 million in clinical manufacturing capacity in Mengeš, Slovenia and […]

September 6, 2022

Charles River Laboratories International, Inc. and Cure AP-4, a non-profit foundation dedicated to raising funds and awareness about Adapter-Protein 4 Hereditary Spastic Paraplegia (AP-4 HSP), have entered a manufacturing collaboration. Charles River, a contract research and development manufacturing organization (CRO/CDMO), […]

September 6, 2022

Hovione announced on September 6, 2022 that it has expanded its continuous manufacturing offering and services with a new manufacturing line, team, and facility. The new continuous manufacturing facility is coming online at the Loures site in Portugal. Hovione is […]

September 2, 2022

With biosimilars entering the market, and more expected to reach the market in the near future, the need for good manufacturing practice (GMP) compliance is growing more crucial for bulk monoclonal antibody (mAb) manufacturing. Beyond innovator biologics, biosimilars are expected […]

August 31, 2022

Cytiva and Forecyte Bio announced on August 25, 2022 that they will collaborate to accelerate the manufacturing and development of the cell and gene therapy industry in China and the United States. The companies will utilize Cytiva’s Fast Trak center […]